Organ-protective effects of adrenomedullin

Hypertension Research

Volumn 26, Issue SUPPL., 2003, Pages

  Shimosawa, Tatsuo ^a   Matsui, Hiromitsu ^a   Xing, Guangqun ^a   Itakura, Kanami ^a   Ando, Katsuyuki ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Knockout mouse; Nitric oxide; Oxidative stress

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE; NITRIC OXIDE; PROADRENOMEDULLIN;

ANTIOXIDANT ACTIVITY; BLOOD PRESSURE REGULATION; CELL PROLIFERATION; FETUS; FETUS GROWTH; GENE TARGETING; GENETIC ENGINEERING; HEART PROTECTION; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; KNOCKOUT MOUSE; LIVER PROTECTION; MOUSE; NONHUMAN; ORGAN INJURY; OXIDATIVE STRESS; REVIEW; SEPTIC SHOCK; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE;

ADRENOMEDULLIN; ANIMALS; HYPERTENSION; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; PEPTIDES;

EID: 0037299218     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.S109     Document Type: Review

References (28)

1. Kitamura K, Kangawa K, Kawamoto M, et al: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560.
2. Kitamura K, Kangawa K, Ishiyama Y, et al: Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett 1994; 351: 35-37.
3. 2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest 1995; 96: 1672-1676.
4. Shimosawa T, Fujita T: Hypotensive effect of newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension 1996; 28: 325-329.
5. Shimosawa T, Ando K, Fujita T: Newly identified peptide, proadrenomedullin N-terminal 20 peptide induces hypotensive action via pertussis toxin-sensitive G-proteins. Hypertension 1997; 30: 1009-1014.
6. Ando K, Ito Y, Kumada M, et al: Oxidative stress increases adrenomedullin mRNA levels in cultured rat vascular smooth muscle cells. Hypertens Res 1998; 21: 187-191.
7. Kawai J, Ando K, Shimosawa T, et al: Regional hemodynamic effects of adrenomedullin in Wistar rats: a comparison with calcitonin gene-related peptide. Hypertens Res 2002; 25: 441-446.
8. Kusaka I, Ishikawa S, Fujita N, et al: Inhibition by adrenomedullin of arginine vasopressin-activated mitogenactivated protein kinase in rat glomerular mesangial cells via cAMP production. Hypertens Res 1996; 19: 113-119.
9. Taylor M, Shimosawa T, Samson W: Endocrine and metabolic action of adrenomedullin. Endocrinologist 2001; 11: 171-177.
10. Kanozawa K, Shimosawa T, Nagasawa R, et al: Mature form of adrenomedullin is a useful marker to evaluate blood volume in hemodialysis patients. Am J Kidney Dis 2002; 40: 794-801.
11. Samson WK, Bode AM, Murphy TC, et al: Antisense oligonucleotide treatment reveals a physiologically relevant role for adrenomedullin gene products in sodium intake. Brain Res 1999; 818: 164-167.
12. Samson WK, Murphy TC: Adrenomedullin inhibits salt appetite. Endocrinology 1997; 138: 613-616.
13. Taylor MM, Samson WK: Ribozyme compromise of adrenomedullin mRNA reveals a physiological role in the regulation of water intake. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1739-R1745.
14. Chao J, Jin L, Lin KF, et al: Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertens Res 1997; 20: 269-277.
15. Dobrzynski E, Wang C, Chao J, et al: Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2000; 36: 995-1001.
16. Zhang JJ, Yoshida H, Chao L, et al: Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats. Hum Gene Ther 2000; 11: 1817-1827.
17. Wang C, Dobrzynski E, Chao J, et al: Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats. Am J Physiol Renal Physiol 2001; 280: F964-F971.
18. Shindo T, Kurihara H, Maemura K, et al: Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 2000; 101: 2309-2316.
19. Shimosawa T, Shibagaki Y, Ishibashi K, et al: Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002; 105: 106-111.
20. Shindo T, Kurihara Y, Nishimatsu H, et al: Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 2001; 104: 1964-1971.
21. Caron KM, Smithies O: Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc Natl Acad Sci USA 2001; 98: 615-619.
22. Kurihara H, Shindo T, Oh-hashi Y, et al: Targeted disruption of adrenomedullin and αCGRP genes reveals their distinct biological roles. Hypertens Res 2003; 26 (Suppl): S105-S108.
23. Nishimatsu H, Hirata Y, Shindo T, et al: Role of endogenous adrenomedullin in the regulation of vascular tone and ischemic renal injury: studies on transgenic/knockout mice of adrenomedullin gene. Circ Res 2002; 90: 657-663.
24. Hayakawa H, Hirata Y, Kakoki M, et al: Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension 1999; 33: 689-693.
25. Hirata Y, Hayakawa H, Suzuki Y, et al: Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 1995; 25: 790-795.
26. Chun T, Rob H, Saito T, et al: Oxidative stress augments secretion of endothelium-derived relaxing peptides, C-type natriuretic peptide and adrenomedullin. J Hypertens 2000; 18: 575-580.
27. Chini E, Chini C, Bolliger C, et al: Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway. Kidney Int 1997; 52: 917-925.
28. Noiri E, Nakao A, Uchida K, et al: Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 2001; 281: F948-F957.